The results showed that both the CML patients had p210 subtype for BCR-ABL, three APL patients had S subtype, and one APL patient had L subtype for PML-RARα (Figure 3). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.